2016 reflections on the favorable cost-benefit of lung cancer screening
By Gabriela Dieguez and Bruce S. Pyenson
23 May 2016
The variation of results in cost-benefit analyses for particular treatments can be bewildering to medical experts unfamiliar with real-world healthcare financing. This article gives a basic background on cost-benefit analyses in healthcare, using lung cancer screening as a case study.
This article was originally published in the Annals of Translational Medicine.